Every day, thousands of people across the world suffer from a variety of facial injuries. In some cases, these injuries are so severe that the skin is completely removed from the face, a condition known as degloving. This article will take a closer look at the gruesome reality of degloved faces, exploring the causes, effects, and treatments for this devastating injury.
Degloving is the medical term for a severe facial injury in which the skin is peeled away from the underlying tissue and bone. This type of injury is most often caused by blunt force trauma, such as a car accident or a fall, but may also be caused by other factors, such as burns or animal bites. Degloving can be partial or complete, depending on the severity of the injury.
When the skin is removed from the face, the underlying tissue and bone are exposed, leading to a wide range of physical and psychological effects. The physical effects of degloving can include severe pain, swelling, and infection. In some cases, the degloved area may also be disfigured, leading to a loss of facial symmetry and a decrease in self-esteem. The psychological effects can be even more devastating, as the trauma of the injury can lead to depression, anxiety, and post-traumatic stress disorder.
Degloving can be a life-altering injury, but with the right treatment, patients can make a full recovery. Treatment typically consists of reconstructive surgery to repair the damaged tissue and bone, as well as skin grafts to replace the lost skin. In some cases, the patient may also need to undergo psychological counseling to manage the psychological effects of the injury.
Degloving is a devastating injury that can cause severe physical and psychological trauma. While the effects of degloving can be severe, with the right treatment, patients can make a full recovery. Doctors should be aware of the causes, effects, and treatments for degloving in order to provide the best care possible for their patients.
1.
More Positive Survival Data in Lung Cancer With Perioperative Therapy
2.
Upfront TKI for Bone-Predominant RCC Tops Single-Agent Immunotherapy
3.
Study finds 10% of pediatric blood cancers may stem from medical imaging radiation
4.
For the creation of cutting-edge targeted radionuclide therapies in oncology, Bayer and Bicycle Therapeutics work together.
5.
Pre-operative evaluation of ovarian cancer patients using DWI-MRI is helpful.
1.
Case Study: Artificial Intelligence in Early Cancer Detection
2.
Understanding Acute Intermittent Porphyria: Symptoms, Diagnosis and Treatment
3.
What is Mullerian and How Does it Affect Your Health
4.
AI in Cancer Care: Transforming Research & Treatment with Deep Learning Technologies
5.
Is p53 the Missing Puzzle Piece? Exploring Its Polymorphisms in Cervical Cancer Risk
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Should We Use DARA Up Front As First-Line Therapy in MM?
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
4.
A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation